Glucose Health, Inc. (GLUC) stock: key figures, P/E, revenue and dividend

Health Care · United States · ISIN US3798941080

Price
0.31 USD
Market cap
8.48 m USD
P/E (2025)
–
P/S (2025)
24.89
Dividend yield
0.00 %
Net margin
-67.72 %
Return on equity (ROE)
-157.16 %
Return on assets (ROA)
-132.16 %

Glucose Health, Inc. financials

Fiscal year20242025
Revenue384,078.00 USD340,659.00 USD
Gross profit75,542.00 USD119,220.00 USD
Operating income-306,555.00 USD-199,804.00 USD
Net income-315,930.00 USD-230,702.00 USD

Full history since 2007, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Glucose Health, Inc.

Glucose Health, Inc. engages in the formulation, manufacturing, marketing, and distribution of soluble fiber infused nutritional beverages. It offers soluble fiber infused powdered iced tea, and flavored drink mixes for pre-diabetic and diabetic persons under the GLUCODOWN brand in North America. The company was formerly known as Bio-Solutions Corp. and changed its name to Glucose Health, Inc. in November 2014. Glucose Health, Inc. was incorporated in 2007 and is based in Bentonville, Arkansas.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 12.11.2026. Details in the risk notice.